AI Science Tracker
EN

Shenzhen Hospital, Beijing University of Chinese Medicine

1 discovery from 2026

Discoveries

Deep-learning flux inference distinguished pancreatic cancer metabolic subtypes

Source check: Source checked. Not independent scientific confirmation.

Finding: Across independent patient cohorts, the study identified glycolytic and lipogenic transcription-factor-defined pancreatic ductal adenocarcinoma subtypes with distinct predicted metabolic programs and prognostic associations. TP63 knockdown shifted cell-line metabolic features, including reduced lactate and increased lipid droplets. scFEA fluxes are model predictions rather than direct intracellular measurements; cell-line perturbations do not establish clinical causality or treatment benefit.

Technology: scFEA deep neural network for metabolic flux inference

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
The learned scFEA model inferred metabolic flux patterns from single-cell RNA-seq, connecting subtype stratification to predicted glycolytic versus lipid/steroid-remodeling programs.
Test and result
Across independent patient cohorts, the study identified glycolytic and lipogenic transcription-factor-defined pancreatic ductal adenocarcinoma subtypes with distinct predicted metabolic programs and prognostic associations. TP63 knockdown shifted cell-line metabolic features, including reduced lactate and increased lipid droplets.
Limitation / still unknown
scFEA fluxes are model predictions rather than direct intracellular measurements; cell-line perturbations do not establish clinical causality or treatment benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2026.1900370/full

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: linked separately.

Review date: 22 Nov 2026. Review scope: Original full-text Methods and Results reviewed from the primary paper or preprint; first result-bearing version checked from the supplied source review; author affiliations checked against exact-DOI metadata where available..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.